Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandra E Peterson

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Pharmacogenomics|June 9, 2012
CYP2D6*11 and challenges in clinical genotyping of the highly polymorphic CYP2D6 geneJennifer M Skierka, Denise L Walker, Sandra E Peterson, et al.
Journal of Personalized Medicine|June 28, 2023
Determination of the Duplicated <i>CYP2D6</i> Allele Using Real-Time PCR Signal: An Alternative ApproachMazen A Atiq, Sandra E Peterson, Loralie J Langman, et al.
Pharmacogenomics|December 7, 2017
Genetic variation in statin intolerance and a possible protective role for UGT1A1Maria Alice V Willrich, Erin J Kaleta, Sandra C Bryant, et al.
Clinical Chemistry|August 11, 2023
Confirmation of Insertion, Deletion, and Deletion-Insertion Variants Detected by Next-Generation SequencingLauren A Choate, Alaa Koleilat, Kimberley Harris, et al.
The Journal of Molecular Diagnostics : JMD|January 18, 2022
Targeted Genotyping in Clinical Pharmacogenomics: What Is Missing?Jaime L Lopes, Kimberley Harris, Mary Beth Karow, et al.
The Journal of Molecular Diagnostics : JMD|March 8, 2016
Preemptive Pharmacogenomic Testing for Precision Medicine: A Comprehensive Analysis of Five Actionable Pharmacogenomic Genes Using Next-Generation DNA Sequencing and a Customized CYP2D6 Genotyping CascadeYuan Ji, Jennifer M Skierka, Joseph H Blommel, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|March 25, 2022
Implementation of preemptive DNA sequence-based pharmacogenomics testing across a large academic medical center: The Mayo-Baylor RIGHT 10K StudyLiewei Wang, Steven E Scherer, Suzette J Bielinski, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Pharmacogenomics|June 9, 2012
CYP2D6*11 and challenges in clinical genotyping of the highly polymorphic CYP2D6 geneJennifer M Skierka, Denise L Walker, Sandra E Peterson, et al.
Journal of Personalized Medicine|June 28, 2023
Determination of the Duplicated <i>CYP2D6</i> Allele Using Real-Time PCR Signal: An Alternative ApproachMazen A Atiq, Sandra E Peterson, Loralie J Langman, et al.
Pharmacogenomics|December 7, 2017
Genetic variation in statin intolerance and a possible protective role for UGT1A1Maria Alice V Willrich, Erin J Kaleta, Sandra C Bryant, et al.
Clinical Chemistry|August 11, 2023
Confirmation of Insertion, Deletion, and Deletion-Insertion Variants Detected by Next-Generation SequencingLauren A Choate, Alaa Koleilat, Kimberley Harris, et al.
The Journal of Molecular Diagnostics : JMD|January 18, 2022
Targeted Genotyping in Clinical Pharmacogenomics: What Is Missing?Jaime L Lopes, Kimberley Harris, Mary Beth Karow, et al.
The Journal of Molecular Diagnostics : JMD|March 8, 2016
Preemptive Pharmacogenomic Testing for Precision Medicine: A Comprehensive Analysis of Five Actionable Pharmacogenomic Genes Using Next-Generation DNA Sequencing and a Customized CYP2D6 Genotyping CascadeYuan Ji, Jennifer M Skierka, Joseph H Blommel, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|March 25, 2022
Implementation of preemptive DNA sequence-based pharmacogenomics testing across a large academic medical center: The Mayo-Baylor RIGHT 10K StudyLiewei Wang, Steven E Scherer, Suzette J Bielinski, et al.
Pageof 1